Latin America Active Pharmaceutical Ingredients Market – Industry Analysis and Forecast (2019-2027) _ by Synthesis Type, by Drug Type, by Manufacturer Type, by Therapeutic Area, and by Geography

Latin America Active Pharmaceutical Ingredients Market is expected to reach US$ 14.8 Bn. at a CAGR of 6.6 during the forecast period 2027. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.

Latin America Active Pharmaceutical Ingredients Market

To know about the Research Methodology:-Request Free Sample Report

Latin America Active Pharmaceutical Ingredients Market Dynamics:

The active pharmaceutical ingredient or API component is responsible for producing the medicinal effects of any drug. The API is also known as active ingredients is form the most important constituent of any drug. The drug comprises two components specifically the API and the excipient. The API component is chemically active and forms the main medication. The excipient component is chemically inert and does not react with the API. The main function of the excipient is to cover the API and transfer it to the human body system. The quantity and type of API are decided by the manufacturer's post considering the pre-notified standards. The API quantity may vary from one brand to another as patients have comparatively more knowledge about API than the excipient.

Latin America Active Pharmaceutical Ingredients Market Segment Analysis:

Synthesis type, drug type, manufacturer type, therapeutic area, and geography are the various segments under the active pharmaceutical market in Latin America. The manufacturer type segment is demarcated into merchant and captive manufacturers. The merchant manufacturers monitored one of the fastest growth owing to the rise in outsourcing of drug formulation by manufacturers. It reduces or eliminates the requirement of heavy investment for a manufacturing process. Considering the synthesis type segment, it is biotech and synthetic that forms two major segments of the active pharmaceutical ingredients market. Growth in R&D activities for biosimilar drugs together with the change in focus of traditional manufacturers towards biological drugs is some major factors that have resulted in the higher growth of the biotech segment. Over-the-counter (OTC), generic, and branded drugs are the three-drug types on the basis of which the market is segmented for active pharmaceutical ingredients. There is a rise in drug prices along with higher spending over healthcare-related R&D activities in Latin America. These have together helped in propelling the demand for branded drugs in the Latin American market for active pharmaceutical ingredients.

Latin America Active Pharmaceutical Ingredients Market Country Analyis:

Brazil is the fastest-growing region as well as the largest in terms of offshore investments. Companies globally are coming to Latin America to manufacturing products at a cheaper labor cost. The infrastructural difficulties still loom at large in this region that is also expected to improve post-government intervention. Overcoming the difficulties related to the healthcare sector coupled with more investments from pharmaceutical companies is expected to improve the growth of the active pharmaceutical ingredients market in Latin America. Active Pharmaceutical Ingredients Market Key Highlights: • Latin America Active Pharmaceutical Ingredients market size analysis and forecast • Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the Latin America Active Pharmaceutical Ingredients Market • Active Pharmaceutical Ingredients market segmentation on the basis of synthesis type, drug type, manufacturer type, therapeutic area, and geography. • Active Pharmaceutical Ingredients market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of a study • Active Pharmaceutical Ingredients market analysis and forecast for major countries have been provided. • Profiling of key industry players, their strategic perspective, market positioning, and analysis of core competencies. • Competitive landscape of the key players operating in the Active Pharmaceutical Ingredients market including competitive developments, investments, and strategic expansion. Active Pharmaceutical Ingredients Market Research Methodology The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply sides were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the market value for Latin America Active Pharmaceutical Ingredients Market.

Active Pharmaceutical Ingredients Market Key Target Audience:

• Healthcare companies • Corporate healthcare entities • Government agencies • Market research and consulting firms • Venture capitalists • Technical Students

Scope of the Active Pharmaceutical Ingredients Market: Inquire before buying

Active Pharmaceutical Ingredients Market, By Synthesis Type

• Biotech • Monoclonal Antibodies • Recombinant Proteins • Vaccines • Synthetic

Active Pharmaceutical Ingredients Market, By Drug Type

• Branded Drugs • Generic Drugs • Over-the-counter (OTC) Drugs

Active Pharmaceutical Ingredients Market, By Manufacturer Type

• Captive Manufacturers • Merchant Manufacturers

Active Pharmaceutical Ingredients Market, By Therapeutic Area

• Cardiology • Pulmonology • Oncology • Neurology • Ophthalmology • Orthopedics • Others

Active Pharmaceutical Ingredients Market, By Geography:

• Latin America • Brazil • Chile • Argentina • Others

Active Pharmaceutical Ingredients Market, Geographic Analysis

• Breakdown of Brazil Active Pharmaceutical Ingredients Market • Breakdown of Chile Active Pharmaceutical Ingredients Market • Breakdown of Argentina Active Pharmaceutical Ingredients Market • Breakdown of Others Active Pharmaceutical Ingredients Market

Key Players Operating in the Latin America Active Pharmaceutical Ingredients Market:

• Blanver EN • Lupin • Nortec Quimica • Synthon • Norkem • Humco • Romikin • Chemo Argentina • RovaFarm • Merck

Available Customizations

Maximize Market Research offers customizations of reports according to the specific requirement of our clients  

Latin America Active Pharmaceutical Ingredients Market

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET VARIABLES & SCOPE 3.1. Market Segmentation & Scope 3.2. Market Driver Analysis 3.3. Market Restraint Analysis 3.4. Penetration &Growth Prospect Mapping 3.5. Market SWOT Analysis, By Factor (political & legal, economic and technological) 3.6. Porter’s Five Forces Industry Analysis 3.7. Market Value Chain Analysis 4. SYNTHESIS TYPE ESTIMATES & TREND ANALYSIS (2019 – 2026) 4.1. Active Pharmaceutical Ingredients Market: Synthesis Type Movement Analysis 4.2. Biotech 4.2.1. Biotech market, 2019 – 2026 (USD billion) 4.2.2. Monoclonal antibodies 4.2.2.1. Monoclonal antibodies market, 2019 – 2026 (USD billion) 4.2.3. Recombinant proteins 4.2.3.1. Recombinant proteins market, 2019 – 2026 (USD billion) 4.2.4. Vaccines 4.2.4.1. Vaccines market, 2019 – 2026 (USD billion) 4.3. Synthetic 4.3.1. Synthetic market, 2019 – 2026 (USD billion) 5. DRUG TYPE ESTIMATES & TREND ANALYSIS (2019 – 2026) 5.1. Active Pharmaceutical Ingredients Market: Drug Type Movement Analysis 5.2. Branded/Innovative Drugs 5.2.1. Branded/Innovative drugs market, 2019 – 2026 (USD billion) 5.3. Generic Drugs 5.3.1. Generic drugs market, 2019 – 2026 (USD billion) 5.4. Over-the-counter (OTC) Drugs 5.4.1. Over-the-counter market, 2019 – 2026 (USD billion) 6. MANUFACTURER TYPE ESTIMATES & TREND ANALYSIS (2019 – 2026) 6.1. Active Pharmaceutical Ingredients Market: Manufacturer Type Movement Analysis 6.2. Captive Manufacturers 6.2.1. Captive manufacturers market, 2019 – 2026 (USD billion) 6.3. Merchant Manufacturers 6.3.1. Merchant manufacturers market, 2019 – 2026 (USD billion) 7. THERAPEUTIC AREA ESTIMATES & TREND ANALYSIS (2019 – 2026) 7.1. Active Pharmaceutical Ingredients Market: Therapeutic Area Movement Analysis 7.2. Cardiology 7.2.1. Cardiology market, 2019 – 2026 (USD billion) 7.3. Pulmonology 7.3.1. Pulmonology market, 2019 – 2026 (USD billion) 7.4. Oncology 7.4.1. Oncology market, 2019 – 2026 (USD billion) 7.5. Neurology 7.5.1. Neurology market, 2019 – 2026 (USD billion) 7.6. Ophthalmology 7.6.1. Ophthalmology market, 2019 – 2026 (USD billion) 7.7. Orthopedics 7.7.1. Orthopedics market, 2019 – 2026 (USD billion) 7.8. Others 7.8.1. Others market, 2019 – 2026 (USD billion) 8. REGIONAL ESTIMATES & TREND ANALYSIS BY SYNTHESIS TYPE, DRUG TYPE, MANUFACTURER TYPE, AND THERAPEUTIC AREA (2019 – 2026) 8.1. Active Pharmaceutical Ingredients Market Share By Region, 2019 & 2026 8.2. Latin America 8.2.1. Latin America active pharmaceutical ingredients market, 2019 – 2026 (USD billion) 8.2.2. Brazil 8.2.2.1. Brazil active pharmaceutical ingredients market, 2019 – 2026 (USD billion) 8.2.3. Chile 8.2.3.1. Chile active pharmaceutical ingredients market, 2019 – 2026 (USD billion) 8.2.4. Argentina 8.2.4.1. Argentina active pharmaceutical ingredients market, 2019 – 2026 (USD billion) 8.2.5. Others 8.2.5.1. Others active pharmaceutical ingredients market, 2019 – 2026 (USD billion) 9. MARKET COMPETITION ANALYSIS 9.1. Strategy Framework 9.2. Company Profiles 9.2.1. Blanver EN 9.2.1.1. Company Overview 9.2.1.2. Financial Performance 9.2.1.3. Product Benchmarking 9.2.1.4. Strategic Initiatives 9.2.2. Lupin 9.2.2.1. Company Overview 9.2.2.2. Financial Performance 9.2.2.3. Product Benchmarking 9.2.2.4. Strategic Initiatives 9.2.3. Nortec Quimica 9.2.3.1. Company Overview 9.2.3.2. Financial Performance 9.2.3.3. Product Benchmarking 9.2.3.4. Strategic Initiatives 9.2.4. Synthon 9.2.4.1. Company Overview 9.2.4.2. Financial Performance 9.2.4.3. Product Benchmarking 9.2.4.4. Strategic Initiatives 9.2.5. Norkem 9.2.5.1. Company Overview 9.2.5.2. Financial Performance 9.2.5.3. Product Benchmarking 9.2.5.4. Strategic Initiatives 9.2.6. Humco 9.2.6.1. Company Overview 9.2.6.2. Financial Performance 9.2.6.3. Product Benchmarking 9.2.6.4. Strategic Initiatives 9.2.7. Romikin 9.2.7.1. Company Overview 9.2.7.2. Financial Performance 9.2.7.3. Product Benchmarking 9.2.7.4. Strategic Initiatives 9.2.8. Chemo Argentina 9.2.8.1. Company Overview 9.2.8.2. Financial Performance 9.2.8.3. Product Benchmarking 9.2.8.4. Strategic Initiatives 9.2.9. RovaFarm 9.2.9.1. Company Overview 9.2.9.2. Financial Performance 9.2.9.3. Product Benchmarking 9.2.9.4. Strategic Initiatives 9.2.10. Merck Inc. 9.2.10.1. Company Overview 9.2.10.2. Financial Performance 9.2.10.3. Product Benchmarking 9.2.10.4. Strategic Initiatives
  • INQUIRE BEFORE BUYING